Iris Dorbian

Iris Dorbian

Opal reels in $15.5 mln Series B

Opal, a collaboration platform for brand marketing teams, has raised $15.5 million in Series B funding. Accel led the round with participation from Madrona Venture Group, Seven Peaks Ventures and MMC Ventures. In addition to the funding, Arun Mathew, a partner at Accel, has been added to Opal's board of directors.

1 min read · 16 February 2017

BioInnovation Capital bags $65.6 mln for maiden fund

BioInnovation Capital has raised $65.6 million for its initial fund, according to an SEC filing. The target was not specified. BioInnovation invests in life science companies.

1 min read · 16 February 2017

TetraVue rakes in $10 mln Series A

TetraVue, a provider of advanced 3D technology, has secured $10 million in Series A funding. Robert Bosch Venture Capital and Nautilus Venture Partners led the round with participation from Samsung Catalyst Fund and Foxconn.

4 min read · 16 February 2017

Get Spiffy takes in $5 mln Series A

Get Spiffy, an on-demand car care, technology, and services company, has secured $5 million in Series A funding. Bull City Venture Partners led the round.

1 min read · 16 February 2017

Mark Wahlberg, Eminem, Courtside Ventures and others back StockX

Detroit-based StockX, an online consumer “stock market of things," has raised $6 million in funding. The investors included Mark Wahlberg, Eminem, Ted Leonsis, Steve Case, Courtside Ventures and Detroit Venture Partners.

1 min read · 16 February 2017

OpenFin inks $15 mln Series B

New York-based OpenFin, a common operating layer for financial desktop applications, has raised $15 million in Series B funding. The investors included Bain Capital Ventures, DRW Venture Capital, J.P. Morgan, Euclid Opportunities, Nyca Partners and Pivot Investment Partners.

1 min read · 16 February 2017

Xcell grabs $12 mln Series A

San Francisco-based Xcell Biosciences, a developer of products in areas that include cancer research, immunology, stem cell biology and cell therapy development, has company secured $12 million in Series A financing. HBM Genomics led the round. In conjunction with the funding, Saeid Akhtari, a managing director of HBM Genomics, has been added to Xcell Biosciences' board of directors.

1 min read · 16 February 2017

Rhythm racks up $41 mln

Boston-based Rhythm, a biopharmaceutical company that focuses on treating life-threatening metabolic disorders, has closed $41 million in financing. The investors included Deerfield Management, Ipsen, OrbiMed, MPM Capital, New Enterprise Associates, Pfizer Venture Investments and Third Rock Ventures.

1 min read · 16 February 2017

ReplyYes picks up $6.5 mln

Seattle-based ReplyYes, an e-commerce over mobile messaging platform for brands to engage with their customers, has raised $6.5 million in Series A funding. Madrona Venture Group, Cross Culture Ventures, Lowercase Capital, Muse Capital and Arnold Venture Group led the round.

1 min read · 16 February 2017

Data platform Immuta nabs $8 mln Series A

College Park, Maryland-based Immuta, a data platform, has secured $8 million in Series A funding. Drive Capital led the round with participation from Greycroft Partners and Conversion Capital.

3 min read · 16 February 2017

Showing 3,121 to 3,130 of 7,132 results
1…312314…714